EMMA

Emmaus Life Sciences, Inc.

USD

Set alert

Price alert · EMMA

All alert types
0.04 USD 0.00 -12.00%
As of Oct 29, 2026
0.03 Day range 0.03
0.0084 52-week range 0.083
YTD
+170.77%
1 year
+238.14%
Open
0.03
Prev close
0.04
Mkt cap
2.47M
Vol
25.86K
Avg vol
122.51K
EPS
-0.09
P/E
0.00
More statistics
Low
0.03
High
0.03
Earnings
Jul 2, 2024

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for EMMA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-26.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.1×
FY 2016: -0.6×FY 2017: -1.5×FY 2018: -0.9×FY 2019: -1.5×FY 2020: 44.4×FY 2021: -5.2×FY 2022: -1.2×FY 2023: -1.4×FY 2024: -0.1×FY 2025: -0.1×
FY 2016 5y median -1.2× FY 2025
P/S 0.1×
FY 2016: 45.3×FY 2017: 129×FY 2018: 37.7×FY 2019: 3.7×FY 2020: 2.6×FY 2021: 4.0×FY 2022: 0.7×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
P/B -0.0×
FY 2016: -15.0×FY 2017: 3.7×FY 2018: 12.3×FY 2019: -7.5×FY 2020: -11.1×FY 2021: -3.8×FY 2022: -0.4×FY 2023: -0.1×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.1× FY 2025
P/FCF -69.4×
FY 2016: -1.3×FY 2017: -3.4×FY 2018: -5.5×FY 2019: -18.2×FY 2020: -2.1×FY 2021: -62.0×FY 2022: -2.5×FY 2023: -3.5×FY 2024: -0.2×FY 2025: -69.4×
FY 2016 5y median -3.5× FY 2025
EV/EBITDA -101×
FY 2016: -1.0×FY 2017: -1.6×FY 2018: -4.6×FY 2019: -3.7×FY 2020: 10.9×FY 2021: -8.6×FY 2022: -7.6×FY 2023: 9.8×FY 2024: -35.3×FY 2025: -101×
FY 2016 5y median -8.6× FY 2025
EV/Sales 2.5×
FY 2016: 42.6×FY 2017: 87.2×FY 2018: 35.7×FY 2019: 4.4×FY 2020: 3.3×FY 2021: 5.3×FY 2022: 2.3×FY 2023: 1.2×FY 2024: 1.9×FY 2025: 2.5×
FY 2016 5y median 2.3× FY 2025
FCF Yield -1.4%
FY 2016: -79.5%FY 2017: -29.6%FY 2018: -18.3%FY 2019: -5.5%FY 2020: -47.6%FY 2021: -1.6%FY 2022: -39.6%FY 2023: -28.6%FY 2024: -427.5%FY 2025: -1.4%
FY 2016 5y median -28.6% FY 2025

Profitability

Gross Margin 93.1%
FY 2016: 93.5%FY 2017: 58.4%FY 2018: 37.1%FY 2019: 95.2%FY 2020: 90.3%FY 2021: 83.9%FY 2022: 85.9%FY 2023: 95.5%FY 2024: 92.8%FY 2025: 93.1%
FY 2016 5y median 92.8% FY 2025
Operating Margin 1.9%
FY 2016: -4426.6%FY 2017: -5528.1%FY 2018: -778.5%FY 2019: -19.8%FY 2020: -0.1%FY 2021: -29.7%FY 2022: -35.8%FY 2023: 12.0%FY 2024: -11.4%FY 2025: 1.9%
FY 2016 5y median -11.4% FY 2025
Net Margin -60.2%
FY 2016: -6981.2%FY 2017: -5535.3%FY 2018: -729.4%FY 2019: -241.0%FY 2020: 5.8%FY 2021: -77.4%FY 2022: -57.8%FY 2023: -12.6%FY 2024: -38.7%FY 2025: -60.2%
FY 2016 5y median -57.8% FY 2025
ROE 11.8%
FY 2016: 2316.2%FY 2017: -156.4%FY 2018: -238.7%FY 2019: 496.2%FY 2020: -25.0%FY 2021: 74.3%FY 2022: 31.2%FY 2023: 7.8%FY 2024: 11.4%FY 2025: 11.8%
FY 2016 5y median 11.8% FY 2025
ROIC -1.2%
FY 2016: 2312.5%FY 2017: -155.0%FY 2018: -256.9%FY 2019: -10.7%FY 2020: -0.1%FY 2021: -14.5%FY 2022: -35.7%FY 2023: 154.4%FY 2024: 18.8%FY 2025: -1.2%
FY 2016 5y median -1.2% FY 2025
ROA -35.0%
FY 2016: -450.0%FY 2017: -116.7%FY 2018: -186.3%FY 2019: -92.2%FY 2020: 2.3%FY 2021: -28.1%FY 2022: -22.0%FY 2023: -10.6%FY 2024: -27.3%FY 2025: -35.0%
FY 2016 5y median -27.3% FY 2025

Growth (YoY)

Revenue -25.2%
FY 2016: -15.0%FY 2017: 51.0%FY 2018: 924.1%FY 2019: 1628.9%FY 2020: 1.8%FY 2021: -11.0%FY 2022: -10.8%FY 2023: 60.9%FY 2024: -43.7%FY 2025: -25.2%
FY 2016 FY 2025
Operating Income 112.2%
FY 2016: -42.2%FY 2017: -88.6%FY 2018: -44.2%FY 2019: 56.0%FY 2020: 99.3%FY 2021: -19050.0%FY 2022: -7.5%FY 2023: 153.8%FY 2024: -153.5%FY 2025: 112.2%
FY 2016 FY 2025
EPS (diluted) -20.0%
FY 2016: -39.4%FY 2017: 72.7%FY 2018: 26.3%FY 2019: 88.4%FY 2020: 102.1%FY 2021: -1255.2%FY 2022: 34.4%FY 2023: 66.5%FY 2024: -42.2%FY 2025: -20.0%
FY 2016 FY 2025
Free Cash Flow 99.5%
FY 2016: -44.4%FY 2017: -60.8%FY 2018: -84.8%FY 2019: 49.6%FY 2020: -524.6%FY 2021: 95.4%FY 2022: -284.3%FY 2023: 70.2%FY 2024: -51.2%FY 2025: 99.5%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 0.8×FY 2017: 3.7×FY 2018: 3.0×FY 2019: 1.3×FY 2020: 0.5×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Quick Ratio 0.1×
FY 2016: 0.7×FY 2017: 3.3×FY 2018: -1.0×FY 2019: 1.0×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Debt / Equity -0.5×
FY 2016: -0.4×FY 2017: 0.0×FY 2018: 0.1×FY 2019: -1.8×FY 2020: -3.5×FY 2021: -1.4×FY 2022: -0.9×FY 2023: -0.7×FY 2024: -0.6×FY 2025: -0.5×
FY 2016 5y median -0.7× FY 2025
Net Debt / EBITDA -98.2×
FY 2016: 0.1×FY 2017: 0.8×FY 2018: 0.3×FY 2019: -0.7×FY 2020: 2.3×FY 2021: -2.2×FY 2022: -5.2×FY 2023: 8.3×FY 2024: -34.7×FY 2025: -98.2×
FY 2016 5y median -5.2× FY 2025
Interest Coverage 0.0×
FY 2016: -1.4×FY 2017: -1076×FY 2018: -119×FY 2019: -0.2×FY 2020: -0.0×FY 2021: -2.0×FY 2022: -1.3×FY 2023: 0.5×FY 2024: -0.3×FY 2025: 0.0×
FY 2016 5y median -0.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31